Results 291 to 300 of about 182,022 (327)
Targeted Anti‐Inflammatory Therapy in Cardiovascular Events: Challenges and Opportunities
ABSTRACT Cardiovascular diseases (CVDs) remain the leading cause of morbidity and mortality globally. Emerging evidence suggests that inflammation plays a pivotal role in the pathogenesis of atherosclerosis and subsequent cardiovascular events. Traditional treatments primarily focus on lipid‐lowering and antithrombotic strategies; however, these ...
Li Feng +3 more
wiley +1 more source
Intratumorally specific microbial-derived lipopolysaccharide contributes to non-small cell lung cancer progression. [PDF]
Sha G +11 more
europepmc +1 more source
ABSTRACT Sepsis frequently progresses to acute lung injury (ALI), characterised by inflammation, extracellular matrix degradation, and mitochondrial dysfunction. This study identifies Enterococcus faecalis as a gut‐derived bacterium that exploits the host fibrinolytic system for pulmonary translocation, resulting in mitochondrial damage and ...
Chenfei Wang +6 more
wiley +1 more source
Correlation of fecal calprotectin levels with the detection of treatable enteric pathogens in children with severe acute diarrheal disease in Botswana. [PDF]
Rehan M +12 more
europepmc +1 more source
Shigella-trained pro-inflammatory macrophages protect zebrafish from secondary infection
Margarida C. Gomes +2 more
openalex +1 more source
We show deletion of an IS200‐encoded sRNA (5′tnpA) in Salmonella impacts the expression of SPI‐1, flagellar, cysteine, and phsABC regulons. Evidence is presented that, with regard to the SPI‐1 regulon, 5′tnpA may function through base pairing with another sRNA known to regulate SPI1 called PinT.
Ryan S. Trussler +7 more
wiley +1 more source
The emergence of sexually transmissible <i>Shigella flexneri</i> serotype 1b between 2019 and 2024 in England: a descriptive epidemiological study. [PDF]
Robinson A +6 more
europepmc +1 more source
A new paradigm of bacteria-gut interplay brought through the study of <bold>Shigella</bold>
Chihiro Sasakawa
openalex +2 more sources

